MUMBAI Aug 31 (Reuters) - The U.S. unit of Indian drugmaker Sun Pharmaceutical (SUN.BO) has received a warning letter from the United States Food and Drug Administration (USFDA) after its New Jersey manufacturing plant was inspected.
MUMBAI Aug 31 (Reuters) - The U.S. unit of Indian drugmaker Sun Pharmaceutical (SUN.BO) has received a warning letter from the United States Food and Drug Administration (USFDA) after its New Jersey manufacturing plant was inspected.
